Lymphocyte activation by low doses of cyclosporin A
Diener, C.; Haroske, D.; Metzner, G.; Jäger, L.
Acta Biologica et Medica Germanica 41(6): 549-552
1982
ISSN/ISBN: 0001-5318 PMID: 7148266 Document Number: 192086
Supernatants of human lymphocyte cultures incubated with cyclosporin A (CS-A) for 90 min reveal an inhibitory effect on the electrophoretic mobility of guinea pig macrophages. This effect is distinctly demonstrated already at CS-A concentrations from 10-7 .mu.g/ml on, with a maximum at 10-3 .mu.g/ml. An inhibitory action of CS-A on PHA).
Document emailed within 1 workday
Related Documents
Kroczek, R.A.; Black, C.D.; Barbet, J.; Shevach, E.M. 1987: Mechanism of action of cyclosporin A in vivo. I. Cyclosporin A fails to inhibit T lymphocyte activation in response to alloantigens Journal of Immunology 139(11): 3597-3603Lazarovits, A.I.; Moscicki, R.A.; Kurnick, J.T.; Camerini, D.; Bhan, A.K.; Baird, L.G.; Erikson, M.; Colvin, R.B. 1984: Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen Journal of Immunology 133(4): 1857-1862
Kelly, R.H.; Wolstencroft, R.A.; Dumonde, D.C.; Balfour, B.M. 1972: Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation Clinical and Experimental Immunology 10(1): 49-65
Schmid, D.S.; Rouse, B.T. 1983: Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors Journal of Immunology 131(1): 479-484
Ashman, R.F. 1990: B lymphocyte activation: the transferrin receptor as a prototype intermediate activation molecule Journal of Laboratory and Clinical Medicine 116(6): 759-765
Cuchacovich, M.; Gatica, H.; Verdaguer, J.I.; Carreño, M.A.; Villarroel, F.; Verdaguer, J. 1999: Treatment of non infectious ocular inflammatory disease with low doses of cyclosporin a Revista Medica de Chile 127(3): 277-285
Fischman, C.M.; Udey, M.C.; Kurtz, M.; Wedner, H.J. 1981: Inhibition of lectin-induced lymphocyte activation by 2-cyclohexene-1-one: decreased intracellular glutathione inhibits an early event in the activation sequence Journal of Immunology 127(6): 2257-2262
Gundersen, D.; Trân-Thang, C.; Sordat, B.; Mourali, F.; Rüegg, C. 1997: Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering Journal of Immunology 158(3): 1051-1060
Bishop, D.K.; Li, W. 1992: Cyclosporin a and FK506 mediate differential effects on T cell activation in vivo Journal of Immunology 148(4): 1049-1054
Bucy, R.P. 1986: Alloantigen-specific suppressor T cells are not inhibited by cyclosporin A, but do require IL 2 for activation Journal of Immunology 137(3): 809-813
Locigno, R.; Antoine, N.; Bours, V.; Daukandt, M.; Heinen, E.; Castronovo, V. 2000: TNP-470, a potent angiogenesis inhibitor, amplifies human T lymphocyte activation through an induction of nuclear factor-kappaB, nuclear factor-AT, and activation protein-1 transcription factors Laboratory Investigation; A Journal of Technical Methods and Pathology 80(1): 13-21
Oppenheim, J.J.; Togawa, A.; Kasahara, S.; Murachi, T. 1980: Assays for lymphocyte activation Rinsho Byori. Japanese Journal of Clinical Pathology 28(11): 1057-1065
Hess, A.D.; Tutschka, P.J. 1980: Effect of cyclosporin a on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR Journal of Immunology 124(6): 2601-2608
Mollison, K.; Dumont, F. 1995: Lymphocyte activation and immunoregulation workshop Agents and Actions. Supplements 47: 181-184
Wedner, H.J. 1988: Recent studies in T lymphocyte activation Year in Immunology 3: 119-128
Bamezai, A.; Rock, K.L. 1994: A role of Ly-6A.2 in T lymphocyte activation and development Brazilian Journal of Medical and Biological Research 27(2): 283-288
Stenzel, K.H.; Schwartz, R.; Rubin, A.L.; Novogrodsky, A. 1978: Potentiation of lymphocyte activation by colchicine Journal of Immunology 121(3): 863-865
Brostoff, J.; Pack, S.; Lydyard, P.M. 1980: Histamine suppression of lymphocyte activation Clinical and Experimental Immunology 39(3): 739-745
Cornaglia-Ferraris, P.; Rossi, E.; Perezzani, L.; Stradi, R. 1991: Retention of amphotericin-B therapeutic efficacy at half doses by synergistic activation of phagocytes Cancer Detection and Prevention 15(4): 327-329
Gelfand, E.W.; Cheung, R.K.; Mills, G.B. 1987: The cyclosporins inhibit lymphocyte activation at more than one site Journal of Immunology 138(4): 1115-1120